Prescription dual GIP/GLP-1 therapy for eligible patients, with medical evaluation and ongoing monitoring built into the plan from the start.
Prescription dual GIP/GLP-1 receptor agonist therapy for eligible patients, following the same standard as every medication we prescribe here: real medical evaluation first, ongoing monitoring built into the plan from day one.
The medication acts on two receptor pathways involved in appetite regulation, prescribed and dosed individually based on your evaluation and response.
An in-person medical evaluation, history review and relevant labs come before any prescribing decision. The visit itself runs about 30 to 60 minutes.
Follow-up appointments track your response and adjust the plan, this is a monitored medical program, not a one-time prescription.
Results vary by individual, adherence and clinical factors, and are not guaranteed. The clinician sets realistic milestones with you rather than promising a specific outcome.
Certain medical histories and medications rule this out, screened honestly at your evaluation, not glossed over to close a sale.
Tirzepatide acts on two receptor pathways involved in appetite regulation (dual GIP/GLP-1), prescribed and dosed individually based on your evaluation and response.
An in-person medical evaluation, history review and relevant labs come before any prescribing decision.
No, follow-up appointments track your response and adjust the plan, this is a monitored medical program, not a one-time prescription.
No, results vary by individual, adherence and clinical factors, and are not guaranteed.
Certain medical histories and medications rule this out, screened honestly at your evaluation, not glossed over to close a sale.
Book a private consultation and let us build a plan that is right for you.
Book a Consultation